Cancer treatment using viruses, fluoropyrimidines and camptothecins
US7767200B2 · kind B2 · utility
1Cited by
8References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2006 |
| Grant date | Aug 3, 2010 |
| Priority date | — |
| Expiry date | Jul 12, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18132
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mammalian subjects having a neoplasm are treated with a virus, a fluoropyrimidine, for example 5-fluorouracil, and a camptothecin compound. The virus is selected from the group consisting of a Newcastle disease virus, a measles virus, a vesicular stomatitis virus, an influenza virus, a Sindbis virus, a picornavirus, and a myxoma virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.